New drug shows promise for rare liver disease in Late-Stage trial

NCT ID NCT05133336

Completed Disease control Sponsor: Zydus Therapeutics Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a drug called saroglitazar magnesium in 196 adults with primary biliary cholangitis (PBC), a chronic liver disease. Participants either took the drug or a placebo to see if it improved liver function markers. The goal was to lower certain liver enzymes and bilirubin levels, which indicate better disease control.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

primary biliary cholangitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PRIMARY BILIARY CHOLANGITIS

Contacts and locations

Locations

Zydus AR001

Buenos Aires, C1118AAT, Argentina
Zydus AR003

Buenos Aires, C1430CKE, Argentina
Zydus AR004

Buenos Aires, B1629ODT, Argentina
Zydus AR005

Buenos Aires, C1125ABE, Argentina
Zydus AR006

Buenos Aires, C1221ADC, Argentina
Zydus AR007

Buenos Aires, C1199ABB, Argentina
Zydus AR009

Buenos Aires, B7600FZO, Argentina
Zydus AR010

Santa Fe, S2002KDS, Argentina
Zydus AR012

Buenos Aires, C1426ABP, Argentina
Zydus AR013

Buenos Aires, C1180AAX, Argentina
Zydus IS001

Reykjavik, IS-101, Iceland
Zydus TR001

Istanbul, 34899, Turkey (Türkiye)
Zydus TR002

Izmir, 35100, Turkey (Türkiye)
Zydus TR003

Istanbul, 34764, Turkey (Türkiye)
Zydus TR004

Ankara, 06800, Turkey (Türkiye)
Zydus TR005

Bursa, 16059, Turkey (Türkiye)
Zydus TR006

Mersin, 33110, Turkey (Türkiye)
Zydus TR008

Gaziantep, 27080, Turkey (Türkiye)
Zydus TR009

Istanbul, 34093, Turkey (Türkiye)
Zydus TR010

Istanbul, 34098, Turkey (Türkiye)
Zydus TR011

Kocaeli, 41380, Turkey (Türkiye)
Zydus TR013

Izmir, 35150, Turkey (Türkiye)
Zydus TR014

Adana, 01790, Turkey (Türkiye)
Zydus TR015

Melikgazi, 38030, Turkey (Türkiye)
Zydus TR016

Altındağ, 06230, Turkey (Türkiye)
Zydus TR017

Cebeli, 06620, Turkey (Türkiye)
Zydus US001

Indianapolis, Indiana, 46202, United States
Zydus US002

Charlotte, North Carolina, 28204, United States
Zydus US004

Houston, Texas, 77030, United States
Zydus US005

Miami, Florida, 33136, United States
Zydus US006

Lakewood Rch, Florida, 34211, United States
Zydus US007

Birmingham, Alabama, 35294, United States
Zydus US011

Pasadena, California, 91105, United States
Zydus US013

Los Angeles, California, 90048, United States
Zydus US014

Cincinnati, Ohio, 45044, United States
Zydus US015

Philadelphia, Pennsylvania, 19141, United States
Zydus US016

Charlottesville, Virginia, 22908, United States
Zydus US019

Tampa, Florida, 33606, United States
Zydus US020

Marietta, Georgia, 30060, United States
Zydus US021

Tucson, Arizona, 85724, United States
Zydus US022

Aurora, Colorado, 80045, United States
Zydus US023

Rochester, Minnesota, 55905, United States
Zydus US024

Omaha, Nebraska, 68105, United States
Zydus US027

Jacksonville, Florida, 32224, United States
Zydus US028

Sarasota, Florida, 34240, United States
Zydus US030

St Louis, Missouri, 63104, United States
Zydus US031

Murray, Utah, 84107, United States
Zydus US033

Seattle, Washington, 98105, United States
Zydus US034

Iowa City, Iowa, 52242, United States
Zydus US035

Rochester, New York, 14642, United States
Zydus US036

Marrero, Louisiana, 70072, United States
Zydus US037

New Haven, Connecticut, 06510, United States
Zydus US038

Manhasset, New York, 11030, United States
Zydus US039

Richmond, Virginia, 23219, United States
Zydus US041

Newport News, Virginia, 23602, United States
Zydus US042

Houston, Texas, 77030, United States
Zydus US043

Sacramento, California, 95817, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.